Kolexia
Artru Pascal Gastro-entérologie
Artru Pascal
Gastro-entérologie
Hopital Prive De L'est Lyonnais (hpel)
Saint-Priest, France
213 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs colorectales Adénocarcinome Métastase tumorale Tumeurs du pancréas Tumeurs du côlon Tumeurs du rectum Tumeurs du foie Instabilité des microsatellites Carcinomes

Collaborateurs

Voir plus
Desrame Jerome
Desrame Jerome
Clinique Du Parc Lyon, Lyon, France
Taieb Julien
Taieb Julien
Hôpital Européen Georges Pompidou, Paris, France
Tougeron David
Tougeron David
Hôpital La Miletrie, Poitiers, France
Bachet Jean Baptiste
Bachet Jean Baptiste
Hôpital Pitie Salpetriere, Paris, France

Industries

Voir plus
Servier
45 collaboration(s)
Dernière en 2023
Mylan Medical
24 collaboration(s)
Dernière en 2022
Amgen
21 collaboration(s)
Dernière en 2023
CanceroDigest
19 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
LAP-NET1: Study Investigating the Association of NP137 With mFOLFIRINOX in Locally Advanced Pancreatic Ductal Adenocarcinoma
Essai Clinique (NETRIS Pharma)   07 mars 2024
NORAD01: Non Inferiority Multicenter Phase III Randomized Trial Comparing Preoperative Chemotherapy Only to Chemotherapy Followed by Chemoradiotherapy for Locally Advanced Resectable Rectal Cancer (Intergroup FRENCH-GRECCAR- PRODIGE)
Essai Clinique (Assistance publique – Hôpitaux de Paris)   05 mars 2024
Triplet chemotherapy with or without bevacizumab as first line treatment for metastatic colorectal cancer: An AGEO multicenter real-world study.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver   24 février 2024
Short course radiotherapy versus radiochemotherapy for locally advanced rectal cancers in the elderly (UNICANCER PRODIGE 42/GERICO 12 study): Quality of life and comprehensive geriatric assessment.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology   08 février 2024
Pemigatinib for patients with previously treated, locally advanced or metastatic cholangiocarcinoma harboring FGFR2 fusions or rearrangements: A joint analysis of the French PEMI-BIL and Italian PEMI-REAL cohort studies.
European journal of cancer (Oxford, England : 1990)   06 février 2024
Prognostic and Predictive Markers of Response to Treatment in Patients With Bile Duct Cancer: ACABi PRONOBIL Study: Marqueurs Pronostiques et prédictifs de réponse Aux Traitements Chez Les Patients Atteints de Cancer Des Voies Biliaires : Cohorte Multicentrique ACABi PRONOBIL
Essai Clinique (GERCOR (Multidisciplinary Group in Oncology))   03 janvier 2024
BACAP-2: Anatomical-Clinical Base of Adenocarcinoma Pancreatic
Essai Clinique (CHU Toulouse)   20 novembre 2023
Prediction of Adjuvant Gemcitabine Sensitivity in Resectable Pancreatic Adenocarcinoma Using the GemPred RNA Signature: An Ancillary Study of the PRODIGE-24/CCTG PA6 Clinical Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology   14 novembre 2023
NACRE: A Phase III Study Evaluating Two Neoadjuvant Treatments Radiochemotherapy (5 Weeks - 50Gy+Capecitabine) and Radiotherapy (1week - 25Gy) in Patient Over 75 With Locally Advanced Rectal Carcinoma
Essai Clinique (Unicancer)   12 octobre 2023
121P PemiBil: Efficacy and safety of pemigatinib in advanced cholangiocarcinoma with FGFR2 fusions/rearrangements in real-world, results of multicentric French cohort from ACABI consortium
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023